CHINA PHARMA HLDGS INC - COM (CPHI)

CUSIP: 16941T104

Q4 2019 13F Holders as of 31 Dec 2019

Share change
+110,211
SEC-reported price per share
$0.24
Indexed holders
6
Value change
+$26,627
Number of buys
3
Number of sells
3

Security key

16941T104

Report period

Q4 2019

Indexed institutions

6

Top holders

5

Ownership snapshot

Top reported holders of CPHI - CHINA PHARMA HLDGS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RENAISSANCE TECHNOLOGIES LLC
Disclosed value leader
RENAISSANCE TECHNOLOGIES LLC
Comparable rows
0/6
Latest evidence
30 Sep 2019
13F Highest disclosed value: $179,000 6 rows are not safely comparable across share classes.

Quick read

RENAISSANCE TECHNOLOGIES LLC has the largest disclosed position value at $179K.

0 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RENAISSANCE TECHNOLOGIES LLC's linked filing trail.
Disclosed position value Top 5
RENAISSANCE TECHNOLOGIES LLC $179K
CITADEL ADVISORS LLC $24K
Virtu Financial LLC $11K
TWO SIGMA SECURITIES, LLC $3K
PARSONS CAPITAL MANAGEMENT INC/RI $2K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 6 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$179,000
731,457 shares
— 30 Sep 2019
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$24,000
99,516 shares
— 30 Sep 2019
Virtu Financial LLC
13F
Company
13F
—
denominator unverified
$11,000
42,883 shares
— 30 Sep 2019
TWO SIGMA SECURITIES, LLC
13F
Company
13F
—
denominator unverified
$3,000
10,577 shares
— 30 Sep 2019
PARSONS CAPITAL MANAGEMENT INC/RI
13F
Company
13F
—
denominator unverified
$2,000
10,000 shares
— 30 Sep 2019
UBS Group AG
13F
Company
13F
—
denominator unverified
$1,000
4,279 shares
— 30 Sep 2019
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
6
Shares
1,008,923
Indexed holders
6
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 indexed holders
6
Q4 2019 indexed holders
6
Indexed holder difference
0
Investor Q3 2019 Shares Q4 2019 Shares Share Diff Share Chg % Q3 2019 value Q4 2019 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .